ATE50496T1 - Verwendung von ''nafazatrom''. - Google Patents

Verwendung von ''nafazatrom''.

Info

Publication number
ATE50496T1
ATE50496T1 AT84100305T AT84100305T ATE50496T1 AT E50496 T1 ATE50496 T1 AT E50496T1 AT 84100305 T AT84100305 T AT 84100305T AT 84100305 T AT84100305 T AT 84100305T AT E50496 T1 ATE50496 T1 AT E50496T1
Authority
AT
Austria
Prior art keywords
nafazatrom
Prior art date
Application number
AT84100305T
Other languages
English (en)
Inventor
Mithat Dr Mardin
Friedel Dr Seuter
Wolf-Dieter Dr Busse
Elisabeth Dr Perzborn
Friedrich Prof Dr Hoffmeister
Volker Dr Fiedler
Klaus Dr Schlossmann
Dieter Prof Dr Mayer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19833302811 external-priority patent/DE3302811A1/de
Priority claimed from DE19833308880 external-priority patent/DE3308880A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Priority claimed from EP84100305A external-priority patent/EP0115789B1/de
Application granted granted Critical
Publication of ATE50496T1 publication Critical patent/ATE50496T1/de

Links

AT84100305T 1983-01-28 1984-01-13 Verwendung von ''nafazatrom''. ATE50496T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19833302811 DE3302811A1 (de) 1983-01-28 1983-01-28 Verwendung von nafazatrom bei der therapie von herzrhythmusstoerungen und myokardischaemien, arzneimittel hierfuer und verfahren zu deren herstellung
DE19833308880 DE3308880A1 (de) 1983-03-12 1983-03-12 Verwendung von nafazatrom als lipoxygenasehemmer, bei der therapie von herzrhythmusstoerungen und ischaemien, sowie von rheumatischen, allergischen und asthmatischen erkrankungen, oedemen, lungenembolien, pulmonaler hypertension, sauerstoffintoxikation und ulcerationen, arzneimittel hierfuer und verfahren zu deren herstellung
EP84100305A EP0115789B1 (de) 1983-01-28 1984-01-13 Verwendung von "Nafazatrom"

Publications (1)

Publication Number Publication Date
ATE50496T1 true ATE50496T1 (de) 1990-03-15

Family

ID=27190727

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84100305T ATE50496T1 (de) 1983-01-28 1984-01-13 Verwendung von ''nafazatrom''.

Country Status (1)

Country Link
AT (1) ATE50496T1 (de)

Similar Documents

Publication Publication Date Title
DE3466986D1 (de) N-phenylsulfonyl-n'-pyrimidinyl- and -triazinylurea
DE3472881D1 (de) N-phenylsulfonyl-n'-pyrimidinyl- and -triazinyl urea
ATE32495T1 (de) Verwendung von hesperidin.
DE69204290D1 (de) Verwendung von 1,2,2,3,3-pentafluorpropan.
IT8449177A1 (it) Composti 5 - eteroarilimidazol - 2 -onici dotati di attivita' cardiotonica
DE3472105D1 (de) 4-heterocyclyl-vinyl-4'-styryl-biphenyls
DE68913397D1 (de) Verwendung von 5-heteroaryl- oder 5-arylsubstituierten Imidazo(2,1-a)isochinolinen.
DE3475713D1 (de) 3, 3", 4" -tri-o-acylspiramycin i
IT1209577B (it) Sintesi dell'aspartame.
FI843110A0 (fi) 4'-halogenantracyklinglykosid.
IT8421933A0 (it) Sostanze ad attivita'ipolipemizzante.
IT1212097B (it) Sintesi dell'aspartame.
DE3481403D1 (de) Verwendung von "nafazatrom".
IT8421955A0 (it) 2-metil-4'-isopropil-2-pentenoilanilide.
ATE50496T1 (de) Verwendung von ''nafazatrom''.
DE69101849D1 (de) Herstellung von Amiden.
DE3779211D1 (de) Verwendung von dihydrobenzopyranderivaten.
DE3882545D1 (de) Verwendung von trifluormethansulfonamid gegen glaukom.
FR2550418B3 (fr) Applicateur d'herbicide perfectionne
ES272849Y (es) "embalaje-presentador mejorado"
SE8305955D0 (sv) All-round-mix "lifestream"
IT8304732V0 (it) Giracitta'
ES272893Y (es) "muneco desmontable"
IT8421763V0 (it) Water-bide'.
ES523310A0 (es) "calcimetro manometrico"

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee